1. OCULAR SURFACE CHANGES IN GLAUCOMA PATIENTS ON LONG-TERM ANTI-GLAUCOMA MEDICATIONS V/S NORMAL PATIENTS.
- Author
-
Malhotra, Reshu, Patel, Santosh Singh, Gupta, Smriti, and Sahu, Anjali
- Abstract
Background: Glaucoma is one of the leading causes of blindness in India. In cases of glaucoma increased intraocular pressure (IOP) is the primary modifiable risk factor. Ocular surface disease (OSD) in these patients results from impaired tear film function and long-term use of antiglaucoma medications. This effect is significant in medications containing benzalkonium chloride (BAK) as a preservative. BAK, though cost-effective, can cause allergic reactions, inflammation, and epithelial damage. Alternative preservatives like Purite® and SofziaTM help mitigate these effects. Reducing the number of medications or using preservative-free options can alleviate OSD and improve patient outcomes. Materials and Methods: An Analytical cross-sectional study to compare the prevalence of ocular surface disease in 61 glaucoma patients and 61 nonglaucoma patients on long-term topical anti-glaucoma medications. The study parameters evaluated include the Ocular surface disease index questionnaire (OSDI) and using the Schirmer 1 test and Tear break-up time (TBUT), ocular surface staining score (OSS) with fluorescein and lissamine green. Results: The prevalence of dry eye disease among glaucoma cases was significantly high at 60.7% compared to 19.7% in the non-glaucoma patients (p<0.01). A marginal tear break-up time (TBUT) was observed in 60.7% of glaucoma patients. Mild to moderate tear deficiency on Schirmer's test was observed in 60.7% of glaucoma patients, while mild to moderate ocular surface disease severity on OSDI was seen in 54.1% (mild) and 6.6%(moderate) of glaucoma patients. Abnormal Ocular surface staining score is seen in 45.9% of glaucoma patients. Conclusion: The presence of dry eye disease in this population is associated with the duration of glaucoma, the number of drugs and the presence of Benzalkonium chloride (BAK) as a preservative in anti-glaucoma drugs. Screening can detect dry eye in glaucoma patients early thus decreasing disease severity and increasing drug compliance. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF